IDEXX Labs (IDXX) Misses Q2 EPS by 9c

IDEXX Labs (NASDAQ: IDXX) reported Q2 EPS of $1.56, $0.09 worse than the analyst estimate of $1.65. Revenue for the quarter came in at $861 million versus the consensus estimate of $864.61 million.

GUIDANCE:

IDEXX Labs sees FY2022 EPS of $7.77-$8.05, versus the consensus of $8.27. IDEXX Labs sees FY2022 revenue of $3.3-3.38 billion, versus the consensus of $3.42 billion.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.

You May Also Be Interested In

• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• Owlet (OWLT) Tops Q2 EPS by 9c
• Aardvark Therapeutics (AARD) Tops Q2 EPS by 21c